#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ehlers-Danlos syndrome Malignant fibrous histiocytoma Encephalitis autoimmune Acute hepatic failure Human papilloma virus immunisation Synovial sarcoma recurrent Autoimmune haemolytic anaemia Autoimmune myositis Autoimmune demyelinating disease Prodromal Alzheimer's disease Hyperchylomicronaemia Primary mediastinal large B-cell lymphoma Myelodysplastic syndrome with excess blasts Wiskott-Aldrich syndrome B-cell small lymphocytic lymphoma More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Trials in Disease Combined immunodeficiency – Treatment KBG syndrome – Diagnostics Myelodysplastic syndrome with excess blasts – Diagnostics Haemophilia B with anti factor IX Hairy cell leukaemia recurrent – Trials in Disease Sarcoma – Diagnostics Rett syndrome – Basic Information Nephrotic syndrome – Treatment Indolent systemic mastocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Salbutamol Sulfate Ph. Eur. Orismilast Mps-214 MZE829 Regadenoson Tavapadon Masupirdine Dextran 70 Elacestrant RIKKUNSHITO Chlorpromazine Hydrochloride Bms-986315 Antipsychotics Ganaxolone ALE1 Aspartic Acid Molgramostim Tusamitamab Ravtansine Jnj-77242113 Dexamethasone Base More therapies…

    Learn about Your Condition

    Rhabdomyosarcoma Endotracheal intubation Hepatitis alcoholic Cardiac disorder Angelman's syndrome Bone sarcoma Colorectal cancer stage II Myasthenia gravis Dry eye Sickle cell disease Gestational diabetes Axial spondyloarthritis Angiosarcoma metastatic Supranuclear palsy Mesothelioma malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Saint Georgi EAD

Bulevard Vasil Aprilov 15a, Plovdiv, 4002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study of SPI-62 for Treating ACTH-Dependent Cushing’s Syndrome in Patients with Cushing’s Disease or Ectopic ACTH/CRH Secretion

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Clofutriben
    Bulgaria Romania

  • Study to Evaluate Plozasiran for Adults with High Triglycerides

    Not recruiting

    3 1
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Bulgaria Czechia France Germany Hungary Italy +3

  • Study to Determine Safe and Effective Dose of Daridorexant for Treating Insomnia in Children and Adolescents Aged 10 to 18 Years

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Insomnia
    Investigated Drugs:
    • Daridorexant
    Bulgaria Germany Italy Spain

  • Study on the Effectiveness and Safety of Barzolvolimab for Patients with Chronic Inducible Urticaria

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cold urticaria
    Investigated Drugs:
    • Barzolvolimab
    Bulgaria Germany Hungary Latvia Lithuania Poland +1

  • Study on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Resiniferatoxin
    • Ropivacaine Hydrochloride
    Bulgaria Poland Romania

  • Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Bulgaria Croatia Germany Hungary Italy Lithuania +4

  • Study on Bepirovirsen for Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    Bulgaria France Germany Greece Hungary Italy +3

  • Study on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction

    Not recruiting

    2 1
    Investigated Drugs:
    • Jtt-861 Monohydrochloride Dihydrate
    Bulgaria Czechia Poland Romania Spain

  • Study on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Bulgaria Czechia Germany Greece Latvia Poland +4

  • Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Tebipenem Pivoxil Hydrobromide
    • Cilastatin
    • Imipenem Anhydrate
    Bulgaria Croatia Estonia Greece Hungary Latvia +3
Previous Page
1 … 12 13 14 15 16 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!